Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369161
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2006-08-25
Brief Title:
A Twelve-month Multicenter Open-label Randomized Study of the Safety Tolerability and Efficacy of Everolimus With Basiliximab Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CRAD001A2426
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceticals